VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients

Amyotrophic Lateral Sclerosis

Volumn 7, Issue 2, 2006, Pages 119-122

  Zhang, Yingshuang ^a   Zhang, Huagang ^a   Fu, Yu ^a   Song, Hongsong ^a   Wang, Liping ^a   Zhang, Jun ^a   Fan, Dongsheng ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Amyotrophic lateral sclerosis; C2578A polymorphism; Vascular endothelial growth factor

Indexed keywords

GENOMIC DNA; VASCULOTROPIN;

ADULT; AGED; ALLELE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RACE DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CHINA; DNA; DOWN-REGULATION; FEMALE; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745063938     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820600600657     Document Type: Article

References (29)

1. Charles, T. and Swash, M. (2001) Amyotrophic lateral sclerosis: Current understanding. J Neurosci Nur, 33, pp. 245-53.
2. Wang, H. and Fan, D. and Zhang, J. and Zhang, H. and Wang, X. and Lu, M. and (2005) Analysis of misdiagnosis of amyotrophic lateral sclerosis pre-admission. Chin J Contemp Neurol Neurosurg, 5, pp. 240-3.
3. Haverkamp, L. J. and Appel, V. and Appel, S. H. (1995) Natural history of amyotrophic lateral sclerosis in a database population. Brain, 118, pp. 707-19.
4. Andersen, P. M. and Sims, K. B. and Xin, W. W. and Kiely, R. and O'Neill, G. and Ravits, J. and (2003) Sixteen novel mutations in the Cu/ Zn superoxide dismutase gene in amyotrophic lateral sclerosis: A decade of discoveries, defects and disputes. ALS Other Motor Neuron Disord, 4, pp. 62-73.
5. Tomkins, J. and Dempster, S. and Banner, S. J. and Cookson, M. R. and Shaw, P. J. (2000) Screening of apendonuclease as a candidate gene for amyotrophic lateral sclerosis. NeuroReport, 11, pp. 1695-7.
6. Veldink, J. H. and van den Berg, L. H. and Cobben, J. M. and Stulp, R. P. and De Jong, J. M. B. V. and Vogels, O. J. and (2001) Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic amyotrophic lateral sclerosis. Neurology, 56, pp. 749-52.
7. Jackson, M. and Morrison, K. E. and Al-Chalabi, A. and Bakker, M. and Leigh, P. N. (1996) Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: Homozygous neuronal apoptosis inhibitor protein deletion in a sporadic case. Ann Neurol, 39, pp. 796-800.
8. Giess, G. and Beck, M. and Goetz, R. and Nitsch, R. M. and Toyka, K. V. and Sendtner, M. (2000) Potential role of the leukaemia inhibitory factor as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis. Neurology, 54, pp. 1003-5.
9. Giess, R. and Holtmann, B. and Braga, M. and Grimm, Y. and Müller-Myhsok, B. and Toyka, K. V. and (2002) Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: Potential impact of the ciliary neurotrophic factor as a candidate modifier gene. Am J Hum Genet, 70, pp. 1277-86.
10. Dechiara, T. M. and Vejsada, R. and Poueymirou, W. T. and Acheson, A. and Suri, C. and Conover, J. C. and (1995) Mice lacking the ciliary neurotrophic factor receptor, unlike mice lacking the ciliary neurotrophic factor, exhibit profound motor neuron deficits at birth. Cell, 83, pp. 313-22.
11. Münch, C. and Ebstein, M. and Seefried, U. and Zhu, B. and Stamm, S. and Landwehrmeyer, G. B. and (2002) Alternative splicing of the 5'-sequences of the mouse excitatory amino acid transporter 2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis. J Neurochem, 82, pp. 594-603.
12. Meier, J. and Couillard-Després, S. and Jacomy, H. and Gravel, C. and Julien, J. (1999) Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. J Neuropath Exp Neur, 58, pp. 1099-110.
13. Greenway, M. J. and Alexander, M. D. and Ennis, S. and Traynor, B. J. and Corr, B. and Frost, E. and (2004) A novel candidate region for ALS on chromosome 14q11.2. Neurology, 63, pp. 1936-8.
14. Tomkins, J. and Banner, S. J. and McDermott, C. J. and Shaw, P. J. (2001) Mutation screening of manganese superoxide dimutase in amyotrophic lateral sclerosis. NeuroReport, 12, pp. 2319-22.
15. Oosthuyse, B. and Moons, L. and Storkebaum, E. and Beck, H. and Nuyens, D. and Brusselmans, K. and (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet, 28, pp. 131-8.
16. Morrison, K. E. (2002) Therapies in amyotrophic lateral sclerosis - beyond riluzole. Curr Opin Pharmacol, 2, pp. 302-9.
17. Lambrechts, D. and Storkebaum, E. and Morimoto, M. and Del-Favero, J. and Desmet, F. and Marklund, S. L. and (2003) The vascular endothelial growth factor is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motor neurons against ischaemic death. Nature Genetics, 34, pp. 383-94.
18. Brooks, B. R. and Miller, R. G. and Swash, M. and Munsat, T. L. (2000) E1 Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 1, pp. 293-9.
19. Yang, B. and Cross, D. F. and Ollerenshaw, M. and Millward, B. A. and Demaine, A. G. (2003) Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complicat, 17, pp. 1-6.
20. Brogan, I. J. and Khan, N. and Isaac, K. and Hutchinson, J. A. and Pravica, V. and Hutchinson, I. V. (1999) Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol, 60, pp. 1245-9.
21. Terry, P. D. and Kamel, F. and Umbach, D. M. and Lehman, T. A. and Hu, H. and Sandler, D. P. and (2004) The vascular endothelial growth factor promoter haplotype and amyotrophic lateral sclerosis. J Neurogenet, 18, pp. 429-34.
22. Carmeliet, P. (2000) Mechanism of angiogenesis and arteriogenesis. Nature Med, 6, pp. 389-95.
23. Sondell, M. and Lundborg, G. and Kanje, M. (1999) The vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci, 19, pp. 5731-40.
24. Schratzberger, P. and Schratzberger, G. and Silver, M. and Curry, C. and Kearney, M. and Magner, M. and (2000) Favourable effect of the vascular endothelial growth factor gene transfer on ischaemic peripheral neuropathy. Nat Med, 6, pp. 405-13.
25. Jin, K. and Zhu, Y. H. and Sun, Y. J. and Mao, X. O. and Xie, L. and Greenberg, D. A. (2002) The vascular endothelial growth factor stimulates neurogenesis in vitro and in vivo. P Natl Acad Sci. USA, 99, pp. 11946-50.
26. Tischer, E. and Mitchell, R. and Hartman, T. and Silva, M. and Gospodarowicz, D. and Fiddes, J. C. and (1991) The human gene for the vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J Biol Chem, 266, pp. 11947-54.
27. Vincenti, V. and Caterina, C. and Rocchi, M. and Persico, M. (1996) Assignment of the vascular endothelial growth factor gene to human chromosome 6P21.3. Circulation, 93, pp. 1493-5.
28. Shahbazi, M. and Fryer, A. A. and Pravica, V. and Brogan, I. J. and Ramsay, H. M. and Hutchinson, I. V. and (2002) Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol, 13, pp. 260-4.
29. Semenza, G. L. (2000) Surviving ischaemia: Adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest, 106, pp. 809-12.